Business Wire6d
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
ECG-AF is one of just a few FDA-authorized medical technologies ... to more broadly support clinicians in identifying patients at increased risk of atrial fibrillation/flutter (AF). Per the CMS policy ...
Business Wire26d
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk TM (landiolol) in ...
Adelaide Now26d
Imricor performs first atrial flutter ablation at Swiss hospital
Imricor Medical Systems has conducted its first cardiac atrial flutter ablation in the brand-new purpose built iCMR lab at the Lausanne University Hospital in Switzerland. It is also the third ...
Morningstar26d
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna ...
Yahoo Finance26d
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
VIENNA, November 27, 2024--(BUSINESS WIRE)--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted ...
Frontiers27d
Left atrial spatial entropy: a novel tool for electrophysiological substrate characterization in atrial fibrillation
Background: Electrical remodeling has been linked to the progression and recurrence of atrial fibrillation (AF) after catheter ablation (CA). Substrate mapping based solely on a voltage amplitude ...